This report answers one question: at a time when Chinese publishers are accelerating their internationalization and Chinese AI companies urgently need high-quality multilingual corpora, which targets in Japanese academic publishing are worth buying, how should they be bought, what are they worth, and where are the risks.
We have five core judgments.
First, Japan is the world's most undervalued pool of academic publishing targets, but the "buy the brand" route is essentially a dead end. Japan ranks fifth globally in research output, has 1,797 journals indexed by OpenAlex, 6 million documents accumulated on the J-STAGE platform, and 2.769 million DOIs registered cumulatively by Japanese Crossref members. But the value of Japanese academic publishing is highly dispersed across 2,728 learned societies and nonprofit organizations, and these organizations do not sell themselves; what is genuinely tradable is their publishing operations, production pipelines, data licenses, and secondary-index assets. Reframing the acquisition target from "publishing houses" to "publishing services + content licensing + data assets" is the greatest point of divergence between this report and conventional M&A thinking.
Second, what China lacks most is not papers but the institutional vehicles capable of carrying them; Japan can supply part of what is missing. In 2023, Chinese authors published 728,700 SCI papers, while Chinese SCI journals carried only 33,400—less than 5%—and this ratio widened from 9.45 times in 2014 to 19.27 times. Using a consistent methodology, this report calculates that China's domestic-journal capacity rate is 5.1% versus 28.4% for Japan, a gap of 5.6 times. Japan's domestic journal capacity in medicine, engineering, materials, chemistry, and agriculture corresponds precisely to the areas where China's shortfall is greatest.
Third, the value of AI corpora is the most tangible and most readily monetizable thread in this acquisition, but it cannot serve as the primary consideration. The global scarcity of high-quality Japanese academic corpora is beyond doubt; however, Article 30-4 of Japan's Copyright Act already provides a relatively broad exception for text and data mining (TDM), and much J-STAGE content is "free but not open" (free to read, with no open license), so the raw accessibility of the corpus is high while its exclusivity is low. What is truly scarce is a corpus that is "machine-readable (full-text JATS XML) + clearly licensed + exclusively licensable": only 7.6% of current J-STAGE journals have full-text XML, and only 95 titles hold DOAJ certification with clear licensing. The value of a corpus comes from processing and exclusivity, not from accessibility. Against benchmarks such as Wiley's roughly US$44 million in annual AI licensing and Taylor & Francis's roughly US$10 million first-year deal with Microsoft, a single Japanese-language corpus transaction is more likely to be below US$10 million in value, making it suitable as a source of synergy gains and deal rationale rather than the core of the valuation.
Fourth, what is most worth buying is not the journals but the "pipeline" and the "index." On the composite six-dimension score, the top three targets are: Kokusai Bunken-sha (Bunken)—the "operating system" of Japanese academic publishing; Igaku-Shoin—Japan's largest commercialization vehicle for medical content; and the collective license for J-STAGE Japanese-language long-tail journals—the lowest unit-cost exclusive corpus. Close behind is the Japan Medical Abstracts Society (Ichushi)—the only systematic index of Japanese clinical and nursing literature. These four targets share one trait: none of them relies on "buying a famous brand"; instead they involve buying processes, relationships, and structured data that others find hard to replicate.
Fifth, the biggest constraint is not money but four compliance chains and one political risk. On the Chinese side, these involve outbound investment filing, foreign exchange, state-owned asset supervision, and listed-company disclosure; on the Japanese side, they involve prior notification under the Foreign Exchange and Foreign Trade Act. More thorny still is the risk to public opinion and academic freedom: once the deal is framed as "Chinese capital controlling Japanese academic publishing," it will fail at the level of the learned societies. This report therefore recommends focusing on licensing, joint ventures, minority stakes, and business succession, avoiding controlling acquisitions, and strictly limiting the public narrative to "enhancing the international dissemination and open access of Japanese research."
Recommendation 1 (0–6 months, can start immediately): use a "corpus pilot" to build relationships and validate value. Start with Japanese-language long-tail journals on J-STAGE, signing a first data-licensing pilot covering roughly 100,000 articles, with investment held to the order of several hundred million yen. This step does not trigger FDI screening or arouse public controversy, yet it can validate the processing pipeline and model returns while building trust for subsequent transactions.
Recommendation 2 (6–18 months, seize the window): acquire a controlling stake in a publishing services company and take over contract publishing for one or two English-language society journals. The mandatory full-text JATS XML submission on J-STAGE before 2029 will create an industry-wide "conversion imperative," making this the most advantageous moment to secure the production pipeline.
Recommendation 3 (18–36 months, build barriers): embed deeply in the J-STAGE ecosystem through a joint venture to build a million-article-scale exclusive Japanese-language corpus. At this stage the objective is no longer a single asset but "reusable international publishing capability + a sustainable corpus supply."
Japanese academic publishing is worth buying, but what must be bought is the processes and data others cannot replicate, not the brands they already own; the most realistic path is a three-step progression of "license first, then pipeline, then platform," rather than a single controlling acquisition.
The structure of Japanese academic publishing differs from that of other countries. In Europe and the United States, learned societies typically hand their journals to commercial publishers and share the revenue, and the publishers themselves are content owners; in China, the right to sponsor a journal and the publishing license are tightly bound to state-owned entities. In Japan, by contrast: learned societies own journal copyright and editorial control, the state provides a free platform, and international publishers take global sales and indexing.
This "three-layer separation" creates a distinctive deal space. Learned societies do not sell themselves, but they have full discretion over their contract publishing relationships; J-STAGE is a national public good, but its service procurement and technical cooperation are open; international publishers control sales, but their contract publishing agreements have terms and renewal windows. In other words, the Japanese market is not one where "there is nothing to buy," but one where what is buyable is not on the conventional M&A checklist.
The platform side presents a different picture: J-STAGE expanded from about 3,000 titles to 4,396, and participating organizations grew from 1,687 to 2,728—the state has done infrastructure very well, but it has not solved the question of who will sell the content to the world.
The Japanese publishing market has declined for four consecutive years, and in 2025 print media fell below 1 trillion yen for the first time (964.7 billion yen, down 4.1% year on year). The professional books and journals segment in which academic publishing sits was hit even earlier: core subsidies for university presses fell from nearly 700 million yen in 2006 to 268 million yen in 2024; the 24 university presses publish only 535 titles a year, and among them Chuo University Press, the only one that discloses its profit and loss, derives 87.4% of revenue from contract publishing and has run a deficit for two consecutive years.
The Physical Society of Japan's PTEP fell into a structural deficit after JSPS funding ended, and APC waivers must be reviewed case by case; learned-society membership is shrinking and competition from commercial publishers is intensifying; mid-sized science and engineering publishers broadly face generational handover. These are not short-term fluctuations but a sustainability crisis—one that has turned institutions that would "never sell" into parties "willing to talk." For a buyer, this is the most favorable condition in valuation negotiations.
The position of academic publishing is further compounded by a "quantity-quality divergence": Japan's share of papers still ranks fifth globally, but its share of highly cited papers has fallen out of the top ten. The declining international influence of journals further weakens learned societies' willingness and ability to publish on their own, making "letting someone else publish the journal" an easier option to accept.
This contraction is equally clear in DOI registration data: annual DOI registrations by Japanese institutions peaked in 2007 and fell from about 59,700 to 45,400 in 2024.
Japanese universities pay 43.03 billion yen a year for foreign journal subscriptions and only 3.45 billion yen for domestic journal subscriptions; Japanese authors paid 12.94 billion yen in APCs in 2023, roughly 18 times the national journal publishing subsidy (711.7 million yen).
The implication of these figures is clear: the Japanese academic community is willing to pay for "better publishing," and most of that money goes to foreign organizations. If a Chinese publisher can improve the editorial quality, international visibility, and open access of Japanese domestic journals, it will face a market that has already been validated and that has stable willingness to pay. This is not new demand that must be cultivated but existing demand that requires replacing the supplier.
In February 2024, Japan's Cabinet Office adopted the "Basic Policy on Immediate Open Access to Academic Papers," requiring immediate green OA for outputs of designated competitive funding, effective from FY2025; in 2026 JST announced that by FY2029 current J-STAGE journals must submit full-text JATS XML, with PDF relegated to a secondary role.
The combination of these two policies creates a clear technical imperative: of Japan's 3,705 current journals, 93.4% currently lack full-text XML capability. Whoever can provide low-cost, high-quality Japanese JATS XML conversion and production services will control the entry point to Japanese academic publishing over the next three years. For a Chinese publisher, this is a faster, cheaper, and harder-to-replace entry point than buying journals.
China Science Publishing's 2019 acquisition of France's EDP Sciences (75 journals) had an enterprise value of only EUR 12 million, officially described as "the first time a Chinese science and technology publisher has completed an acquisition of a Western publishing institution in a truly meaningful sense." By comparison, Wiley paid US$298 million for Hindawi, and KKR paid US$1.62 billion for Simon & Schuster.
The valuation anchor for academic journal assets is more than an order of magnitude lower than that for trade publishing. Japanese targets are generally smaller and have weaker international influence, so their reasonable valuations should fall in an even lower range. Combined with the yen's long-term weakness, Chinese buyers enjoy a clear cost advantage.
This report does not rely on the intuition that "a big name means a good buy"; instead it builds a reproducible six-dimension scoring model. Each dimension is scored from 0 to 5, weighted, converted to a 100-point scale, and a risk score is deducted separately.
| Dimension | Weight | What it measures | Characteristics of a score of 5 |
|---|---|---|---|
| D1 Strategic leverage | 22% | Whether it can materially raise the Chinese publisher's global standing | High international visibility, a Q1 brand, a global distribution network |
| D2 Discipline fit | 20% | Whether it fills a disciplinary gap in China's domestic journals | A high China gap ratio with large absolute volume, plus existing capacity in Japan |
| D3 Transferability | 18% | Whether the ownership structure permits a transaction | Corporatized, under financial pressure, no exclusive contracts |
| D4 AI corpus value | 27% | Corpus scale, scarcity, processability, exclusivity | Japanese-language exclusive, structured, clear chain of rights |
| D5 Valuation and financials | 13% | How well price matches synergy value | Cheap, clean cash flow, no hidden liabilities |
| D6 Integration and compliance risk | −18% | The probability of deal and integration failure (negative deduction) | The lower the risk, the lower the score and the smaller the deduction |
Under a traditional publishing lens, this weight would seem excessive. But in the specific context of this transaction, corpus value has three properties no other dimension possesses: first, it can be monetized without obtaining control, thus bypassing the biggest political and compliance obstacles; second, it is the only value source that can be "validated at small scale first and then scaled up"; third, it is a direct source of synergy gains, and Chinese AI companies' willingness to pay for Japanese-language corpora provides additional valuation support for an otherwise unremarkable cash-flow publishing asset.
It should be emphasized that D6 is a risk dimension and is subtracted in the composite score. We deliberately place "existing high-impact English-language journals" in the middle-to-lower ranks of their categories—because their contract publishing agreements are mostly locked up long term by OUP, Springer Nature, Wiley, and IOP, making them the most tempting on the surface and the hardest to obtain in practice. This is where the model differs most from intuition.
The radar chart makes the differences among the leading targets clearer: Kokusai Bunken-sha scores high on both transferability and corpus value; Ichushi earns a perfect score on corpus value but its transferability is constrained by its legal form; and the society journal portfolios are stronger on strategic leverage and weaker on transferability.
Once Japanese academic publishing is broken into five layers, the distribution of "acquirability" becomes clear. The content-owning layer (learned societies and universities) is almost entirely non-acquirable; the services-and-platform layer is partly acquirable; and the monetization layer (international publishers) is not in Japan at all. This determines the feasible set for this transaction.
| Layer | Representative organizations | Tradable? | Tradable form |
|---|---|---|---|
| Learned societies (gakkai) | Japan Society of Mechanical Engineers, Physical Society of Japan, Pharmaceutical Society of Japan, etc. | Entity: no / Business: yes | Contract publishing succession, data licensing, joint ventures |
| University presses | University of Tokyo Press, Keio University Press, etc. | Rarely / Partly | Co-editions, translation rights, digital distribution joint ventures |
| Domestic commercial publishers | Igaku-Shoin, Ohmsha, Asakura Shoten, etc. | Yes | Equity acquisition, business transfer |
| Publishing services and production | Kokusai Bunken-sha, Nakanishi Printing, CAPJ | Yes | Equity acquisition (the most typical M&A target) |
| Secondary indexes and data | Ichushi, JAICI, JST/J-GLOBAL | Partly / No | Data licensing, joint ventures (national institutions cannot be acquired) |
One boundary must be stated clearly: there is not a single "internationally scaled" publisher in Japanese academic publishing. The Japanese publishing organization with the highest OpenAlex coverage is JSME (about 316,000 records, after excluding sources with anomalous metadata), followed by the Japan Neurosurgical Society, the Japanese Circulation Society, the Pharmaceutical Society of Japan, and the Physical Society of Japan. Nowhere in Japan is there an entity approaching the scale of Elsevier, Springer Nature, or Wiley. This means acquiring Japanese targets cannot buy a global platform in one step, only a set of capability components—which is precisely why this report recommends a "portfolio transaction."
Another noteworthy phenomenon: the most internationalized Japanese journals are almost all in the hands of international publishers. The chart below plots "document volume × two-year average citations," and the high-impact journals in the upper right—Gastric Cancer, Cancer Science, Polymer Journal, and Hypertension Research—are overwhelmingly published under contract by Springer Nature, Wiley, and others.
The copyright of Japanese academic journals belongs almost entirely to learned societies. Learned societies are public-interest corporations or incorporated associations and cannot be acquired like companies, but substantive control or use rights can be obtained in three ways: taking over contract publishing (the most direct), signing data and translation licenses (the lightest), and establishing a joint-venture publishing company (the heaviest but most stable).
JSME is the Japanese institution with the largest DOI registration volume—Crossref records 338,673 DOIs, more than four times the runner-up. It publishes Japanese-language proceedings, English-language journals, and a large number of conference proceedings, with about 316,000 records covered by OpenAlex.
Its value lies not in its impact factor (JSME International Journal has only average international visibility) but in the irreplaceability of Japanese-language engineering application literature: a great deal of process detail in machinery, materials, robotics, and precision machining exists only in Japanese, and China's engineering discipline has the largest absolute shortfall of any field (in 2023 Chinese authors produced 207,000 papers while domestic journals carried 12,700, a gap ratio of 16.4 times).
JPSJ is Japan's physics flagship (about 45,000 records, h-index 239), and PTEP is an open-access theoretical physics journal. After JSPS funding ended, PTEP fell into a structural deficit and APC waivers must be reviewed case by case—the clearest "financial distress signal" in the entire pool. For a buyer, this means the society has a genuine incentive to seek a new publishing partner.
But physics happens to be a discipline China is relatively less short of (a gap ratio of only 8.9 times, among the lowest of all disciplines). The model therefore ranks the physics target mid-pack: it is a good "relationship entry point" and "credibility vehicle," but not the most urgently needed discipline-fill target.
JJAP and APEX are currently published under contract by IOP Publishing, which has had a Tokyo office since 2002. Applied physics, semiconductors, and materials are precisely the fields where China's "chokepoint" problems and weak domestic journals coexist. The contract with IOP is a ready-made negotiation interface—contract expiry or renewal is the window for a new tender.
BCSJ (about 38,700 records, two-year average citations 3.65, h-index 169) and Chemistry Letters (about 30,300 records) are in the first tier of Japanese domestic journals. But as of January 2024, the Chemical Society of Japan has transferred the publishing operations of these two journals to Oxford University Press.
This case is highly instructive: it proves that "society-international publisher" contract relationships do change, and that change windows genuinely exist. But it also shows that for a Chinese buyer to take over such an asset it must offer terms better than OUP's—a matter not just of price but of brand and trust. This is why the model gives the chemistry target a D3 transferability score of only 2.6.
The Pharmaceutical Society of Japan (CPB 29,200 records, Yakugaku Zasshi 25,400 records, and BPB 11,400 records, with BPB now in DOAJ) and the journal portfolios of the various clinical medicine societies are the content assets with the highest discipline-fill value:
The society journal portfolios have high strategic value and low transferability. The right approach is not "acquisition" but "succession + licensing": take over the contract publishing of English-language journals to obtain global distribution rights, and license the full-text data of Japanese-language journals to obtain corpora. The former requires an 18-to-36-month contract window; the latter can start immediately.
If only one transaction can be made, this report recommends directing it at this layer. The reason: they do not hold journal copyright and are therefore not bound by society ownership; they are corporatized and therefore acquirable; and what they possess are processes and relationships, which are extremely hard to replicate.
Since 1995, Kokusai Bunken-sha has taken on society-secretariat outsourcing and has supported J-STAGE since 2002, covering submission systems, peer-review workflows, typesetting and production, full-text XML conversion, and DOI and PMC registration—essentially the entire workflow of a journal from submission to launch. It serves a large number of learned societies, which amounts to controlling the operational pipeline and customer network of Japanese academic publishing.
Why this ranks first in the pool (composite score 72.9):
Key risk: customers (learned societies) are extremely sensitive to changes in control. The transaction must therefore be designed to "retain the existing management, the existing brand, and the existing service commitments," and the announcement must explicitly state that "service terms for Japanese learned societies will not change." This is not rhetoric but a precondition for the deal to succeed.
Founded in 1865, Nakanishi Printing likewise handles society editorial office operations and academic typesetting, and has partnered with Oxford University Press since 1999. Together with Kokusai Bunken-sha it forms a comparable in the same lane: smaller in scale, longer in history, and more privately held.
Generational handover is the typical sale trigger for family-run printing businesses of this kind. For a buyer, Nakanishi Printing's value lies in providing a price reference and an alternative, and it may transact at a lower valuation. The model gives it a composite score of 66.8 and a D5 valuation feasibility of 4.2 (higher than Bunken), reflecting the fact that it is "cheaper but somewhat narrower in capability."
CAPJ was established by the University of Tokyo Press in 1971 as a 20th-anniversary project and is a nonprofit incorporated foundation. It cannot be acquired, but it can serve as a joint-venture partner or business successor, and its nonprofit status can serve as a buffer for public opinion and compliance.
Recommended use: when a controlling transaction is sensitive, use CAPJ as the nominal entity to take on sensitive business, with the Chinese side providing technology and capital. This can significantly reduce the narrative risk of "Chinese capital controlling Japanese academic publishing."
The distinguishing feature of this category is that its value lies not in full texts but in structured indexes. For AI training, secondary literature with controlled subject terms, abstracts, and classification codes is often more efficient than raw full text—because annotation density is higher and noise is lower.
Ichushi is the only systematic secondary index of Japanese clinical and nursing literature, containing tens of millions of Japanese-language medical records and abstracts. Its irreplaceability rests on three points:
The model gives it D4 = 5.0 (a perfect score): among all 25 targets, it delivers the highest AI corpus value density per unit of investment.
Main obstacle: the Japan Medical Abstracts Society is a nonprofit corporation and cannot be acquired through equity. The realistic path is data licensing, joint development, or joint-venture operation. In addition, the Japanese side is highly sensitive to cross-border flows of medical data—"data stays in Japan, the model is trained domestically, and only model capability is delivered" may be the only feasible structure.
JAICI is the Japanese agent for CAS and STN, providing chemical structure, literature, and patent search services. Chemical and patent data has direct value for materials and pharmaceutical AI, but JAICI does not hold copyright in original content and is easily substituted (CAS and Reaxys internationally already cover similar needs). The model therefore gives it a composite score of only 54.7, placing it second in Category C.
JST is a national research and development agency, and its Current Bibliography and J-GLOBAL are national infrastructure and cannot be acquired. This report includes it in the target pool to draw a clear "non-tradable boundary": the state-dominated portion of Japan's academic information system (J-STAGE, JaLC, CiNii, and J-GLOBAL) can only be partnered with, not acquired. Any valuation model that counts it as an acquisition target is wrong.
Commercial publishers are the only category that can be handled under conventional M&A logic: corporatized, with clear equity, financial statements, and negotiability. But individually they are all small, and their content is mainly textbooks and professional books. The core recommendation of this report is therefore "bundling" rather than "picking one star publisher."
Igaku-Shoin has revenue of about 10.69 billion yen (FY2021) and owns roughly 30 clinical monthlies plus a large number of medical and nursing textbooks, making it Japan's largest medical publisher. Its value has three layers:
The model gives it a composite score of 68.2 and a D2 discipline fit of 4.6: it is the most complete target, combining content, channels, and brand in one. Generational handover at Japanese family businesses is the typical sale trigger for companies of this kind.
Ohmsha's contract printing business covers the journals of IEEJ, IEICE, and the Information Processing Society of Japan (IPSJ), while it also publishes a large number of science and engineering textbooks. Its strategic significance lies in its dual identity: as a publisher it is acquirable; as a contract printer for society journals it is a springboard for accessing Category A society assets.
The model gives it a composite score of 66.9, including a D3 transferability of 4.0—against the backdrop of Category A assets being broadly non-tradable, "buying the interface" is a pragmatic alternative.
Mid-sized publishers such as Asakura Shoten, Shokabo, Kyoritsu Shuppan, Tokyo Kagaku Dojin, and Uchida Rokakuho all face the twin pressures of market contraction and generational handover. Individually they are all small, but bundled together they can form a complete corpus of Japanese-language STM textbooks and professional books, covering foundational disciplines such as mathematics, physics, chemistry, biology, and engineering.
The model gives it a D5 valuation feasibility of 4.4 (among the highest in the pool), because the transaction prices of such assets are likely to be extremely low. Its drawback, however, is a D1 strategic leverage of only 2.4: fragmented brands, limited synergy, and high due diligence costs.
First, there must be a unified digital processing pipeline, otherwise buying the copyrights to hundreds of books will not produce a usable corpus; second, there must be a unified distribution entry point, otherwise management costs cannot be amortized; third, the positioning of "low strategic value, high corpus value" must be accepted, and no international brand should be expected from this batch of assets.
Japan has 24 university presses (members of the Association of Japanese University Presses), which together published 535 titles in 2025. Their legal forms vary: foundations, associations, stock companies, and even units within universities. Only a very few of them, in corporate form, offer any possibility of an equity transaction.
University of Tokyo Press is the leading brand among Japanese university presses, releasing 123 new titles in 2025 (23% of the association total) and more than 8,300 titles cumulatively, with English-language books distributed through Columbia University Press. The quality of its Japanese studies and humanities content is extremely high.
But it is an incorporated foundation, deeply tied to the University of Tokyo, and there is almost no possibility of acquisition. The model gives it a D3 transferability of only 1.6. The realistic path is co-editions, translation licensing, and digital distribution partnerships.
Keio University Press released 78 new titles in 2025, second in the association, and is organized as a stock company. Among AJUP members, its ownership structure comes closest to being tradable. Its content spans the humanities and social sciences, economics, law, and medicine.
The model gives it D3 = 2.8 (the highest in Category E). Note, however: even if it is legally tradable, as one of Japan's top private universities Keio would still present substantial public-opinion and governance resistance.
Chuo University Press is very small (21 titles in 2025), but it is the only university press in Japan that discloses complete profit and loss figures: contract publishing accounts for 87.4% of revenue, it has run a deficit for two consecutive years, and it has publicly commented on the contraction in professional book retailing.
For a buyer seeking "low-cost exposure to Japanese publishing operations," it is an ideal small-scale pilot. The model gives it D3 = 3.4 and D5 = 3.6. It is recommended as the first target for a "joint venture plus debt-restructuring-style cooperation," rather than as a source of economic return.
First, do not overestimate the transferability of the brand. A university press's brand is inseparable from its university; buying the press is not the same as buying the reputation of "the University of Tokyo." Second, do not underestimate how slow governance is. Foundations have long decision chains, and a single transaction may take more than two years.
This is the category this report most wants to emphasize, and the one most easily overlooked from a conventional M&A perspective.
J-STAGE hosts 3,705 current journals and 6 million accumulated documents from 2,728 publishing organizations. Of these, purely Japanese-language journals number about 818 and Japanese-Chinese mixed journals about 868. The individual impact factors of these journals are negligible and international citations are extremely low, making them worthless from the standpoint of "buying a journal brand."
But from an AI corpus perspective, they are the world's largest, most disciplinarily complete, and most exclusive collection of Japanese academic texts, and moreover:
The model gives Category F targets D4 = 5.0 and D5 = 4.6, for a composite score of 68.2 and a joint second-place ranking.
More than 80% of J-STAGE content can be read for free, but this does not amount to an open license. Data from 2022 show that of 3,632 J-STAGE journals, only 214 (about 6%) are genuinely open access (with explicit reuse licenses), while 2,943 (about 81%) are merely "free to read." With content that is free to read, you cannot stop competitors from reading it too.
The value of long-tail corpora must therefore be built on processing and exclusivity, not on raw accessibility:
These three things are precisely the capabilities of Category B publishing services companies. Hence this report repeatedly stresses: Category F corpora and the Category B pipeline are two ends of the same business and should be pursued together.
The value of an acquisition must land on specific disciplines. Using a consistent methodology, we calculated the "domestic journal capacity rate" for China and Japan alike (domestic journal output ÷ domestic author output, 2023, OpenAlex basis), producing a map that can directly guide target screening.
The most critical finding is that Japan is not strong in every discipline, and the distribution of China's shortfalls is partly mismatched with Japan's strengths. This requires distinguishing three categories of disciplines:
| Category | Characteristics | Representative disciplines | Acquisition implication |
|---|---|---|---|
| Double-high: large Chinese gap + existing Japanese capacity | Highest discipline-fill value | Medicine, engineering, materials, chemistry, agriculture, pharmacy | Prioritize resource allocation |
| Single-high: large Chinese gap but Japan is also weak | Limited discipline-fill value | Quantum science, medical informatics, computer science-cybernetics, nursing | Should not be relied on Japan; build domestically |
| China strong and Japan strong | Competitive | Physics, mathematics, earth sciences | Use as a credibility and relationship vehicle, not for gap-filling |
| Discipline | Chinese author output | Chinese journal capacity | Gap ratio | Japanese journal capacity | Japan capacity rate |
|---|---|---|---|---|---|
| Business administration | 12,635 | 193 | 65.5 | 276 | 30.2% |
| Veterinary medicine | 395 | 7 | 56.4 | 61 | 44.9% |
| Dentistry | 1,983 | 41 | 48.4 | 397 | 47.4% |
| Arts and humanities | 4,458 | 106 | 42.1 | 415 | 35.9% |
| Economics and econometrics | 14,592 | 374 | 39.0 | 502 | 35.6% |
| Psychology | 9,715 | 256 | 37.9 | 744 | 27.1% |
| Nursing | 3,780 | 104 | 36.3 | 227 | 31.1% |
| Decision sciences | 5,725 | 173 | 33.1 | 214 | 32.3% |
| Social sciences | 21,352 | 765 | 27.9 | 1,557 | 32.3% |
| Health professions | 3,835 | 141 | 27.2 | 695 | 35.7% |
| Biochemistry and molecular biology | 66,136 | 2,436 | 27.1 | 2,531 | 23.2% |
| Medicine | 121,682 | 4,588 | 26.5 | 11,522 | 25.6% |
| Immunology and microbiology | 9,933 | 386 | 25.7 | 392 | 19.9% |
| Neuroscience | 11,632 | 461 | 25.2 | 789 | 22.9% |
| Computer science | 57,406 | 2,585 | 22.2 | 1,809 | 32.4% |
| Pharmacology and pharmaceutics | 3,245 | 149 | 21.8 | 341 | 37.3% |
| Agricultural and biological sciences | 36,878 | 1,887 | 19.5 | 1,381 | 32.7% |
| Chemistry | 20,884 | 1,136 | 18.4 | 640 | 20.3% |
| Environmental science | 57,666 | 3,175 | 18.2 | 2,208 | 32.3% |
| Materials science | 62,429 | 3,523 | 17.7 | 1,600 | 20.9% |
| Physics and astronomy | 25,036 | 2,807 | 8.9 | 848 | 11.2% |
One mismatch must be pointed out honestly: the frontier fields that Chinese official assessments identify as needing their "gaps filled"—quantum science and technology, medical informatics, computer science-cybernetics, developmental biology, substance abuse, and biodiversity conservation—are precisely the fields in which Japan is also weak. Buying Japan cannot fill China's most frontier gaps. What Japan can fill is clinical medicine, engineering applications, materials processing, chemistry, and agriculture—fields that are "mature in system but lagging at the frontier." Clarifying this mismatch is more valuable than saying in general terms that "Japanese journals are worth buying."
| Metric | Value | Basis and source |
|---|---|---|
| J-STAGE cumulative published documents | 6.002 million | Fiscal year-end FY2025, including proceedings |
| Current J-STAGE journals | 3,705 | From 2,728 publishing organizations |
| Cumulative DOIs from Japanese Crossref members | 2.769 million | 723 members, 1.59% of the global total |
| Of which with full-text JATS XML | 281 (7.6%) | FY2025; overseas publishers approach 100% |
| DOAJ open-license certification | 95 (0.40%) | Out of 23,555 worldwide |
| Purely Japanese-language current journals | about 818 | J-STAGE 2024 language structure |
| Japanese-English mixed current journals | about 868 | Same as above |
Assuming an average of 8,000–12,000 tokens per article, 6 million documents correspond to a raw token volume of between 48 billion and 72 billion. Even if only 20% of that is structurally processed, it amounts to high-quality Japanese academic corpora on the order of 10 billion tokens—a considerable increment for multilingual large models.
Another signal favorable to the corpus case: China is already J-STAGE's third-largest overseas readership. In FY2025, China downloaded from J-STAGE 81.9 million times, accounting for 12.0% of all downloads. This means Chinese researchers have genuine demand for Japanese-language content itself, and the downstream application scenarios for corpus building already exist.
But "accessible" is by no means the same as "usable." The comparison in the chart below is critical: Japan's green OA rate is only 3.2%, far below that of the United States, the United Kingdom, Germany, and France; at the same time, only 95 Japanese journals have genuinely obtained open-license certification.
First, processing beats collection. The value of a raw PDF is close to zero; once structurally encoded in XML, OCR-corrected, and annotated with terminology and entities, a corpus can increase in value by an order of magnitude. Second, exclusivity beats scale. A corpus anyone can download does not constitute a barrier; an exclusivity period, proprietary annotations, or a proprietary index does. Third, the chain of rights beats quantity. An article with unclear rights is a liability, not an asset. Prioritize journals where authors retain rights or that already carry CC licenses.
| Target | Corpus scale | Language scarcity | Degree of structuring | Transferability of rights | Overall corpus value |
|---|---|---|---|---|---|
| Ichushi | Tens of millions of abstract records | Extremely high (Japanese-language exclusive) | Extremely high (controlled subject terms) | Medium (requires license negotiation) | Five stars |
| J-STAGE long-tail journals | 6 million documents | Extremely high | Low (7.6% XML) | Medium-high (requires collective negotiation) | Five stars |
| Kokusai Bunken-sha | Already processing full texts of 244 journals | High | High (proprietary XML pipeline) | High (acquired upon acquisition) | Four and a half stars |
| Clinical medicine journal portfolio | Large, dispersed | High | Medium | Medium | Four and a half stars |
| Pharmaceutical society journal portfolio | 75,000 documents | High | Medium | Medium | Four stars |
| Ohmsha | Science and engineering textbooks and society journals | Medium-high | Low | High | Three and a half stars |
Article 30-4 of Japan's Copyright Act provides a relatively broad exception for text and data mining, not resting solely on a "non-enjoyment purpose" requirement, but it retains a proviso for "unfairly prejudicing the interests of the rights holder"; at the same time, it does not apply where the use is for "enjoyment purposes." This means the legal risk of conducting model training within Japan is significantly lower than in Europe and the United States.
But the requirements on the Chinese side are stricter: the Interim Measures for the Administration of Generative AI Services require training data to be lawfully sourced and not infringe intellectual property. Therefore, when obtaining corpora from Japan, an explicit authorization permitting cross-border use for model training must be secured in the contract; it is not enough to rely on Japan's TDM exception alone.
One reality must be faced squarely: as of now, there is no publicly disclosed case of a Chinese AI company purchasing Japanese-language academic corpora. This is not because demand does not exist, but because the path has not yet been blazed—for a first mover, this is both a risk and an opportunity.
Among Japanese academic publishing targets, aside from a few listed companies (such as Maruzen CHI Holdings) and organizations that disclose segment profit and loss (such as Chuo University Press), the overwhelming majority do not disclose financial data. Japanese local research institutions likewise cannot produce a reliable industry valuation multiple—because the targets are unlisted and comparable transactions are lacking. Any claim that "Japanese academic publishers are valued at an average of 8 times EBITDA" is fabricated.
This report therefore adopts bottom-up order-of-magnitude estimates rather than a multiples approach.
| Transaction / contract | Nature of target | Amount | Relevance to this transaction |
|---|---|---|---|
| China Science Publishing's acquisition of France's EDP Sciences (2019) | Whole-acquisition of 75 academic journals | Enterprise value EUR 12 million | The most direct comparable anchor: the actual price magnitude for a Chinese publisher acquiring a Western publishing asset |
| Wiley's acquisition of Hindawi (2021) | OA journal platform | About US$298 million | The upper bound for platform-type asset valuation |
| Primates moving back from Springer to a Japanese society (2025) | Return of contract publishing rights | Not disclosed | Proves that contract publishing relationships can be reversed |
| Wiley's annual AI licensing (2024) | Full-text corpus licensing | About US$44 million | The revenue magnitude of corpus licensing |
| Taylor & Francis and Microsoft (first year) | Full-text corpus licensing | About GBP 8 million | The median magnitude of a corpus transaction |
| Axel Springer and OpenAI (three years) | Content licensing | Tens of millions of euros | A reference for content-model cooperation |
| Phoenix Media's acquisition of PIL (2014) | Children's book publishing assets | US$80 million | A price reference for a Chinese buyer entering a Japan-related market |
Based on the above anchors and the scale of the three target categories, this report offers the following order-of-magnitude ranges (all labeled as estimates, not quotations):
| Target type | First-phase investment magnitude | Primary pricing basis |
|---|---|---|
| Long-tail corpus licensing pilot (about 100,000 articles) | Several hundred million yen | Per article or per token, including processing |
| Controlling stake in a publishing services company (Kokusai Bunken-sha scale: revenue 1.877 billion yen) | Billions to tens of billions of yen | Revenue or EBITDA multiple, subject to due diligence confirmation |
| Bundle of mid-sized commercial publishers | Several hundred million to several billion yen | Negotiated on assets and copyright packages |
| University press cooperation | Tens of millions to several hundred million yen | Based on project and co-edition agreements |
| Secondary-index data licensing (Ichushi scale) | Several hundred million to several billion yen per term | Based on data scale, exclusivity scope, and term |
The US dollar traded at 144.4 yen in April 2025 and rose to 160.7 yen in June 2026; the renminbi rose against the yen from 20.58 in August 2025 to 23.56 in August 2026. The yen weakened by about 14% against the renminbi, meaning Japanese assets are becoming cheaper in renminbi terms. At the same time, note that Chinese state-owned entities face stricter notification requirements in Japan (see the next section), so the exchange-rate advantage and institutional constraints must be weighed together.
Core principle: exchange the minimum control for the maximum right to use content and data.
Step one is Path One (within 6 months, a few hundred million yen, to validate value and build relationships); step two is Path Two plus Path Five (6–18 months, to secure the pipeline and XML capability); step three is Path Three at the contract window (18–36 months, to take over English-language journals); Path Four serves throughout as a pilot and trust-building exercise. Never aim to "buy up Japanese academic publishing," but rather to "become an indispensable service and data partner to it."
This is the most important divergence between this report and common assumptions. After reviewing notifications from Japan's Ministry of Finance, the current positive list of "designated business sectors" (Appended Tables 1 and 2) does not include publishing (4141), the news industry, academic societies, or research institutes; nor does the list of "core business sectors" include publishing. Therefore, acquiring a Japanese publisher or publishing services company alone generally does not trigger a prior notification obligation, requiring only an ex post report.
But there are two key exceptions:
Operational recommendations: (1) obtain a formal legal opinion from a Japanese lawyer that "publishing is not a designated business sector"; (2) prioritize a market-oriented entity without a state-owned background or a joint-venture SPV as the transaction vehicle to avoid the strict rules for "foreign governments, etc."; (3) continue tracking the implementing details of the 2026 amendment.
Risk one: academic freedom and public backlash (high probability, high impact). This is the factor most likely to cause the deal to fail, and no financial clause can defuse it. Japanese academia is highly sensitive to "Chinese capital controlling academic publishing." Response: strictly limit the public narrative to "enhancing the international dissemination and open access of Japanese research"; do not replace editors-in-chief, interfere in topic selection, or alter editorial board composition; preserve full Japanese autonomy over editorial matters in the governance structure and lock it in through the charter.
Risk two: an incomplete copyright chain (medium probability, high impact). AI training uses require a clear rights basis. Author copyright arrangements in Japanese journals are not uniform, and co-author consents and third-party figure permissions may both be missing. Response: prioritize journals where authors retain rights or that already carry CC licenses; for long-tail corpora, use "title-by-title confirmation plus indemnity warranty clauses"; require the licensor in the license agreement to make representations and warranties regarding the completeness of rights.
Risk three: exclusivity in existing contracts (high probability, medium impact). The contract publishing agreements of most high-impact English-language journals are locked up long term by OUP, Springer Nature, Wiley, and IOP (public samples run about 3 to 3.5 years; 3 to 5 years is inferred), and exit clauses are not disclosed. Response: secure renewal windows in advance; compete on "service upgrade commitments" rather than "price"; for targets still within contract terms, pursue data licensing first and negotiate publishing rights once the contracts expire.
| Risk | Description | Response |
|---|---|---|
| Cross-border corpus compliance | Japan's TDM exception is permissive, but China requires lawful sourcing | Obtain explicit cross-border training authorization in the contract |
| Data export | Medical data and "important data" are sensitive | Keep data in Japan and deliver only model capability |
| Integration and governance | Japanese employees and the tradition of society autonomy | Retain the existing team and brand; establish a local governance committee |
| Geopolitics and exchange rates | Fluctuations in Japan-China relations; a weak yen | Use the exchange-rate window; keep structures reversible and stepwise |
| Overvaluation | Mistaking "freely visible" for "exclusively usable" | Base valuation on exclusivity scope rather than accessibility scope |
| Data | Source | Basis notes |
|---|---|---|
| Journal and publisher metrics | OpenAlex API | Source country field; sources with anomalous metadata (source merges) excluded; two-year average citations, not JCR impact factor |
| DOIs and member registration | Crossref REST API | Full scan of all 33,849 members, locally aggregated |
| Open access certification | DOAJ public metadata | License and APC structures |
| Platform statistics | JST J-STAGE FY2025 | Holdings, number of organizations, XML readiness rate, download geography |
| National research output | NISTEP, Kagaku Gijutsu Shihyo 2025 (Science and Technology Indicators 2025) | Fractional counting |
| Library expenditure | JUSTICE annual survey | Member library basis |
| University publishing | Association of Japanese University Presses (AJUP) | 24 members, new title bulletins |
| FDI screening | Ministry of Finance notifications and law firm interpretations | Positive list of designated business sectors |
Composite score = 100 × (0.22×D1 + 0.20×D2 + 0.18×D3 + 0.27×D4 + 0.13×D5) ÷ 5 − 18 × D6 ÷ 5
Here D1–D5 are better the higher they are, and D6 is the risk score (worse the higher it is, and subtracted). All sub-scores are based on the evidence in the body of this report and can be reproduced item by item in japan_ma/scripts/ma_data.py.
This report contains three irreducible uncertainties that must be clearly communicated to decision-makers:
Do not ask "which Japanese publishers can be bought," but rather "which link in the Japanese academic publishing chain can others not replicate and I can operate at lower cost." The answer is not on a list of publishers but in three places: production pipelines, structured data, and long-tail corpora.
The table below lists the six-dimension scores and composite scores of all 25 candidate targets. D1 strategic leverage, D2 discipline fit, D3 transferability, D4 AI corpus value, and D5 valuation and financial feasibility are all scored 0 to 5 (higher is better); D6 is integration and compliance risk (higher is worse, and is subtracted). The composite score formula is in Appendix A.
| Rank | Target | Category | D1 | D2 | D3 | D4 | D5 | D6 | Composite |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Kokusai Bunken-sha (Bunken) | B | 3.6 | 3.6 | 4.6 | 4.6 | 3.8 | 1.8 | 75.0 |
| 2 | Nakanishi Printing Co., Ltd. | B | 3.0 | 3.2 | 4.4 | 4.2 | 4.2 | 1.8 | 69.0 |
| 3 | Igaku-Shoin | D | 3.2 | 4.6 | 3.8 | 4.4 | 3.2 | 2.8 | 68.2 |
| 4 | Collective license for J-STAGE Japanese-language long-tail journals (1,700+ titles) | F | 2.0 | 4.2 | 3.6 | 5.0 | 4.6 | 2.6 | 68.2 |
| 5 | Japan Medical Abstracts Society (Ichushi-Web / Ichushi) | C | 3.0 | 4.8 | 2.6 | 5.0 | 3.2 | 2.6 | 67.7 |
| 6 | Portfolio of Japanese clinical medicine society journals (Japanese Society of Internal Medicine / Japanese Circulation Society / Japanese Society of Gastroenterology / Japanese Cancer Association, etc.) | A | 3.6 | 5.0 | 2.2 | 4.8 | 3.4 | 3.2 | 67.0 |
| 7 | Ohmsha | D | 3.2 | 4.2 | 4.0 | 4.0 | 3.6 | 2.6 | 66.9 |
| 8 | Portfolio of Pharmaceutical Society of Japan journals (CPB / BPB / Yakugaku Zasshi) | A | 3.8 | 4.4 | 2.6 | 4.2 | 3.4 | 2.8 | 65.1 |
| 9 | Portfolio of JSME journals and conference papers | A | 3.0 | 4.8 | 2.4 | 4.6 | 3.6 | 3.2 | 63.7 |
| 10 | Portfolio of IEICE journals | A | 3.8 | 4.5 | 2.6 | 4.0 | 3.4 | 3.0 | 63.7 |
| 11 | Journals and conference proceedings of the Japanese Psychological Association | A | 2.2 | 5.0 | 2.6 | 4.2 | 4.0 | 2.4 | 63.5 |
| 12 | Journals and proceedings of JSCE | A | 2.8 | 4.6 | 2.4 | 4.4 | 3.8 | 2.8 | 62.9 |
| 13 | Japan Society of Applied Physics journals (JJAP / APEX) | A | 4.2 | 4.2 | 3.0 | 3.4 | 3.4 | 3.0 | 62.5 |
| 14 | Materials journal portfolio of the Japan Institute of Metals and Materials / the Iron and Steel Institute of Japan | A | 3.2 | 4.4 | 2.4 | 4.2 | 3.6 | 2.8 | 62.3 |
| 15 | Portfolio of IEEJ journals | A | 2.8 | 4.4 | 2.4 | 4.4 | 3.8 | 2.8 | 62.1 |
| 16 | Portfolio of Physical Society of Japan journals (JPSJ / PTEP) | A | 4.0 | 3.4 | 3.6 | 3.2 | 4.0 | 2.8 | 61.8 |
| 17 | Architectural Institute of Japan (AIJ) proceedings | A | 2.6 | 4.4 | 2.4 | 4.4 | 3.8 | 2.8 | 61.2 |
| 18 | Bundle of mid-sized science, engineering, and natural science publishers (Asakura Shoten, Shokabo, Kyoritsu Shuppan, Tokyo Kagaku Dojin, Uchida Rokakuho, etc.) | D | 2.4 | 3.8 | 4.0 | 3.8 | 4.4 | 3.4 | 59.9 |
| 19 | Flagship journals of the Chemical Society of Japan (BCSJ / Chemistry Letters) | A | 4.6 | 3.8 | 2.6 | 3.0 | 3.0 | 3.4 | 56.6 |
| 20 | Japan Association for International Chemical Information (JAICI) | C | 2.4 | 3.6 | 2.4 | 4.2 | 3.0 | 2.6 | 54.7 |
| 21 | Center for Academic Publications Japan (CAPJ) | B | 2.4 | 2.8 | 2.6 | 3.6 | 3.4 | 1.8 | 52.9 |
| 22 | Keio University Press | E | 3.0 | 3.2 | 2.8 | 3.4 | 3.0 | 2.6 | 52.9 |
| 23 | University of Tokyo Press | E | 3.6 | 3.4 | 1.6 | 3.8 | 2.4 | 2.6 | 52.6 |
| 24 | Chuo University Press | E | 1.8 | 2.8 | 3.4 | 2.8 | 3.6 | 2.4 | 47.2 |
| 25 | Assets related to JST Current Bibliography on Science and Technology / J-GLOBAL | C | 2.0 | 3.4 | 0.6 | 4.0 | 2.0 | 4.2 | 36.2 |
Category codes: A society journal portfolios; B publishing services and production; C secondary indexes and data; D commercial publishers; E university presses; F long-tail corpora.
D1 Strategic leverage examines whether a target can materially raise the Chinese publisher's global standing (international visibility, Q1 brands, distribution networks); D2 discipline fit is based on measured domestic capacity rates for China and Japan (see the discipline-fill map in the body); D3 transferability is based on legal form, financial pressure, and the degree of contractual exclusivity; D4 AI corpus value is based on scale, Japanese-language scarcity, degree of structuring, and transferability of rights; D5 valuation and financials examines how well price matches synergy value; and D6 aggregates FDI screening, public-opinion, copyright, and integration risks.
All quantitative conclusions in this report can be traced to the public sources listed below. Any judgment marked as unverified is explained in the body.